Thalidomide vs argon plasma for GAVE anemia in cirrhosis
Treatments studied
Part of Digestive system, Heart & circulation clinical trials.
This trial compares two treatments for anemia caused by abnormal blood vessels in the stomach (GAVE) in people with cirrhosis. It tests whether a medicine called thalidomide is better than a procedure that uses a tiny argon plasma beam to stop bleeding, to see which helps treat anemia more effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with cirrhosis (scarred liver).
- You have a stomach condition called GAVE (abnormal blood vessels in the stomach lining) confirmed by a scope exam.
- You have iron deficiency anemia (low iron causing tiredness, pale skin, etc.).
- You are not pregnant, don't have severe nerve damage, and don't have a history of blood clots.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two tests (ROTEM and TEG) that help doctors decide which blood products to give to cirrhosis patients with active stomach or intestinal bleeding that is not from varices. The goal is to find which test works better.
This trial compares two drugs, terlipressin and somatostatin, to see which better controls bleeding from varices in patients with cirrhosis who also have kidney problems. The goal is to find a treatment that improves outcomes for this serious situation.
This study tests a freezing spray (Tru-Freeze) to treat GAVE, a condition that causes stomach bleeding. It may help people who need blood transfusions because of GAVE and have had few or no prior endoscopic treatments.
This trial tests whether combining thalidomide and glutamine helps people with bleeding caused by past radiation treatment to the abdomen or pelvis. The medication may reduce inflammation and help healing.
This trial tests a procedure called endoscopic radiofrequency treatment to see if it can reduce the need for blood transfusions in people with GAVE, a condition that causes bleeding in the stomach. If you have ongoing bleeding or anemia despite iron therapy, this treatment might help stop the bleeding.
This trial tests different doses of thalidomide to see if it can reduce or eliminate the need for blood transfusions in people with beta thalassemia major or intermedia.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.